Wegovy is a medication that contains semaglutide
Key points about Wegovy dosing: Administered once weekly via subcutaneous injection Should be taken on the same day each week Can be given at any time of day, with or without meals Injection sites include abdomen, thigh, or upper arm Consistent timing supports treatment effectiveness and helps establish a sustainable routine While Wegovy is licensed for adults with a BMI 30 kg/m (obesity) or 27 kg/m with weight-related comorbidities, NHS availability through specialist weight management services follows NICE guidance (TA875), which has specific eligibility criteria including BMI thresholds (with ethnicity adjustments) and prior interventions
Common side effects of Ozempic and semaglutide include nausea, vomiting, diarrhea, constipation, and abdominal pain, which are usually mild and improve over time
This is the first trial to demonstrate cardiovascular benefit with a weight-management medication in people without diabetes
Jerry: And you work crazy hours and at some point you just look up and you just like, well, I guess this is my body type
They may be able to recommend Wegovy alternatives that are more affordable
